LOADING
Comparing Johnson & Johnson (JNJ) and Intel Corporation (INTC) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | INTC |
|---|---|---|
| Price | $271.82 | $88.16 |
| Change Today | +0.58% | -2.12% |
| Market Cap | $651.3B | $476.1B |
| P/E Ratio | 31.4 | -- |
| Forward P/E | 23.2 | 70.9 |
| PEG Ratio | 4.73 | 0.50 |
| EPS | $8.62 | $-2.09 |
| Revenue Growth (YoY) | 6.6% | 25.4% |
| Profit Margin | 21.5% | -19.8% |
| Return on Equity | 25.7% | -10.7% |
| Dividend Yield | 1.96% | -- |
| Beta | 0.23 | 2.24 |
| 52-Week High | $276.47 | $142.35 |
| 52-Week Low | $170.33 | $23.68 |
| Volume | -- | 118 |
Johnson & Johnson is the larger company by market capitalization. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.